![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ||
Founding Date | Founding Date 1948 | Founding Date 2006 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations Emeryville, US HQ Maidenhead, GB | |
Employees | Employees 6515% increase | Employees 741% increase |
Financial | ||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) |
Net income | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) |
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company